Hong Seng Consolidated Berhad (KLSE:HONGSENG) - Prezzo delle azioni, notizie e analisi

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

HONGSENG Panoramica delle azioni

Hong Seng Consolidated Berhad, una holding di investimento, si occupa di produzione di guanti e NBL, di servizi sanitari e finanziari in Malesia e Australia.

Informazioni sull'azienda

HONGSENG analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	0/6
Prestazioni passate	0/6
Salute finanziaria	5/6
Dividendi	0/6

Premi

Negoziato a 92.5% al di sotto della nostra stima del suo valore equo

Analisi del rischio

Prezzo delle azioni altamente volatile negli ultimi 3 mesi

Non ha una capitalizzazione di mercato significativa ( MYR77M )

Non ha entrate significative ( MYR15M )

Hong Seng Consolidated Berhad Concorrenti

Smile-Link Healthcare Global Berhad

KLSE:SMILE

RM 39.1m

DC Healthcare Holdings Berhad

KLSE:DCHCARE

RM 214.2m

Optimax Holdings Berhad

KLSE:OPTIMAX

RM 361.3m

Metro Healthcare Berhad

KLSE:MHCARE

RM 388.5m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Hong Seng Consolidated Berhad
Prezzi storici delle azioni
Prezzo attuale dell'azione	RM 0.015
Massimo di 52 settimane	RM 0.055
Minimo di 52 settimane	RM 0.005
Beta	2.11
1Variazione di 1 mese	50.00%
Variazione a 3 mesi	50.00%
Variazione di 1 anno	-70.00%
3Variazione a 3 anni	-98.20%
Variazione a 5 anni	-72.09%
Variazione dall'IPO	-74.77%

Notizie e aggiornamenti recenti

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Jun 09

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Oct 12

Recent updates

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Jun 09

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Oct 12

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?

May 11

We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt

Jan 27

Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching

Jan 04

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Nov 30

Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns

Oct 26

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Aug 31

We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease

Aug 09

Rendimenti per gli azionisti

	HONGSENG	MY Healthcare	MY Mercato
7D	50.0%	0.6%	0.2%
1Y	-70.0%	9.9%	14.1%

Ritorno vs Industria: HONGSENG ha avuto una performance inferiore rispetto al MY Healthcare che ha registrato un rendimento 8.7 % nell'ultimo anno.

Rendimento vs Mercato: HONGSENG ha avuto una performance inferiore al mercato MY che ha registrato un rendimento 13.6 % nell'ultimo anno.

Volatilità dei prezzi

Is HONGSENG's price volatile compared to industry and market?
HONGSENG volatility
HONGSENG Average Weekly Movement	65.5%
Healthcare Industry Average Movement	4.2%
Market Average Movement	6.1%
10% most volatile stocks in MY Market	11.5%
10% least volatile stocks in MY Market	2.8%

Prezzo delle azioni stabile: Il prezzo delle azioni di HONGSENG è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale di HONGSENG è aumentata da 48% a 66% nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2001	321	n/a	www.hongseng.com.my

Hong Seng Consolidated Berhad, una holding di investimento, si occupa di produzione di guanti e NBL, servizi sanitari e finanziari in Malesia e Australia. Opera attraverso i segmenti Sanità, Servizi finanziari e guanti, Ricerca e pubblicità e altri segmenti. L'azienda offre servizi di diagnostica medica e di laboratorio di ricerca, vendita all'ingrosso di prodotti farmaceutici e medici e servizi di prestito di denaro.

Hong Seng Consolidated Berhad Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Hong Seng Consolidated Berhad con la sua capitalizzazione di mercato?
HONGSENG statistiche fondamentali
Capitalizzazione di mercato	RM 76.63m
Guadagni(TTM)	-RM 61.22m
Ricavi(TTM)	RM 14.95m

5.1x

Rapporto P/S

-1.3x

Rapporto P/E

HONGSENG è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
HONGSENG Conto economico (TTM)
Ricavi	RM 14.95m
Costo del fatturato	RM 37.58m
Profitto lordo	-RM 22.63m
Altre spese	RM 38.59m
Guadagni	-RM 61.22m

Ultimi guadagni dichiarati

Mar 31, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	-0.012
Margine lordo	-151.40%
Margine di profitto netto	-409.58%
Rapporto debito/patrimonio netto	3.8%

Come si è comportato HONGSENG nel lungo periodo?

Vedi performance storica e confronto

HONGSENG Panoramica delle azioni

Premi

Analisi del rischio

Hong Seng Consolidated Berhad Concorrenti

KLSE:SMILE

RM 39.1m

KLSE:DCHCARE

RM 214.2m

KLSE:OPTIMAX

RM 361.3m

KLSE:MHCARE

RM 388.5m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Hong Seng Consolidated Berhad, Annual General Meeting, Aug 29, 2024

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Less than half of directors are independent

New minor risk - Financial data availability

Hong Seng Consolidated Berhad Announces the Resignation of Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Recent updates

Hong Seng Consolidated Berhad, Annual General Meeting, Aug 29, 2024

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Less than half of directors are independent

New minor risk - Financial data availability

Hong Seng Consolidated Berhad Announces the Resignation of Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Third quarter 2023 earnings released: RM0.001 loss per share (vs RM0.004 profit in 3Q 2022)

New major risk - Share price stability

Hong Seng Consolidated Berhad Announces Cessation of Teoh Soon Han as Alternate Director

Second quarter 2023 earnings released: RM0.002 loss per share (vs RM0.008 profit in 2Q 2022)

Hong Seng Consolidated Berhad Appoints Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?

Hong Seng Consolidated Berhad entered into a Shares Sale Agreement to acquire Alliance EV Sdn Bhd from CSH Alliance Berhad for MYR 20 million.

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.016 in FY 2021)

Hong Seng Consolidated Berhad agreed to acquire 51% stake in Innov8tif Holdings Sdn Bhd from Innov8tif Consortium Sdn Bhd for MYR 30.9 million.

Hong Seng Consolidated Berhad, Annual General Meeting, Feb 27, 2023

We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt

Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.013 in FY 2021)

Hong Seng Consolidated Berhad Reports Impairment Charges for the Fourth Quarter Ended September 30, 2022

High number of new and inexperienced directors

Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns

Hong Seng Consolidated Berhad Appoints Tea Sor Hua as Company Secretary, Effective October 1, 2022

Hong Seng Consolidated Berhad Announces Re-Designation of Tuan Ng Keok Chai from Member of Remuneration Committee to Chairman of Remuneration Committee

Hong Seng Consolidated Berhad Appoints Dato Kang Chez Chiang as Independent and Non Executive Member of Nomination Committee

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Hong Seng Consolidated Berhad Reports Plant and Equipment Written Off for the Quarter Ended June 30, 2022

Third quarter 2022 earnings released: EPS: RM0.004 (vs RM0.013 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Hong Seng Consolidated Berhad Appoints Dato Mohamed Suffian Bin Awang as Independent and Non Executive Chairman

Hong Seng Consolidated Berhad, Annual General Meeting, Feb 25, 2022

Second quarter 2022 earnings: Revenues miss analyst expectations

Robust Potential Sdn Bhd entered into an agreement to acquire Hong Seng Priority Management Sdn Bhd from Hong Seng Consolidated Berhad (KLSE:HONGSENG) for MYR 34.5 million.

Senior Independent Non-Executive Director Mun Wong has left the company

Full year 2021 earnings released: EPS RM0.022 (vs RM0.025 loss in FY 2020)

Hong Seng Consolidated Berhad Announces Appointment of Mr. Christopher Chan Hooi Guan as Executive Director

Independent Non Executive Director has left the company

Hong Seng Consolidated Berhad Resigns Ym Tengku Farith Rithauddeen as Independent and Non Executive Independent Director

Hong Seng Consolidated Berhad Resigns Tengku Farith Rithauddeen as Independent and Non Executive Chairman of Nomination Committee

Third quarter 2021 earnings released: EPS RM0.006 (vs RM0.002 loss in 3Q 2020)

Hong Seng Consolidated Berhad Announces Resignation of Mr. Lim Peng Tong as Executive Director

New 90-day high: RM1.35

New 90-day high: RM1.15

Second quarter 2021 earnings released: EPS RM0.003

New 90-day low: RM0.99

Hong Seng Consolidated Berhad (KLSE:HONGSENG) entered into a share sale agreement to acquire remaining 49% stake in HS Bio Supplies Sdn Bhd from United ICT Consortium Sdn. Bhd. For MYR 0.98 million.

MSCM Holdings Berhad Announces Cessation of Wong Yee Ming as Non-Independent and Non-Executive Alternate Director

First quarter earnings released

New 90-day high - RM1.50

Landasan Simfoni Sdn Bhd entered into a share sale agreement to acquire 47.19% sake in MSCM Holdings Berhad (KLSE:MYSCM) from MMag Holdings Berhad (KLSE:MMAG) for MYR 0.75 million.

New 90-day high - RM0.20

Rendimenti per gli azionisti

Volatilità dei prezzi